From the Guidelines
The standard starting dose for Humulin M3 is typically 10 units per day or 0.1–0.2 units/kg/day, depending on the degree of hyperglycemia, as recommended by the most recent guidelines 1.
Key Considerations for Insulin Therapy
- Humulin M3 is a premixed insulin containing 30% soluble insulin (regular) and 70% isophane insulin (NPH), designed to provide both immediate and intermediate-acting coverage.
- The dose should be administered subcutaneously 30 minutes before meals, usually breakfast and dinner.
- Insulin requirements vary significantly between individuals based on factors such as weight, insulin sensitivity, carbohydrate intake, physical activity level, and concurrent medications.
Adjusting the Dose
- Blood glucose monitoring is essential when starting insulin therapy, and the dose should be adjusted gradually based on pre-meal and bedtime glucose readings.
- Hypoglycemia is the most common side effect of insulin therapy, so patients should be educated about recognizing and treating low blood sugar episodes.
- The initial dose is intentionally conservative to minimize this risk, with the expectation that upward adjustments will likely be needed over time, as supported by recent studies 1.
Important Factors to Consider
- The progressive nature of type 2 diabetes should be regularly and objectively explained to patients, and insulin therapy should not be delayed in patients not achieving glycemic goals 1.
- Equipping patients with an algorithm for self-titration of insulin doses based on self-monitoring of blood glucose improves glycemic control in patients with type 2 diabetes initiating insulin 1.
- Comprehensive education regarding self-monitoring of blood glucose, diet, and the avoidance of and appropriate treatment of hypoglycemia are critically important in any patient using insulin 1.
From the Research
Standard Starting Dose for Humilin M3
The standard starting dose for Humilin M3 is not explicitly stated in the provided studies. However, some information can be gathered from the following points:
- In the study 2, seven normal volunteers received 20 IU of each insulin subcutaneously, including Humulin M3, in a randomized fashion on separate days.
- There is no direct information on the standard starting dose for Humilin M3 in the other studies 3, 4, 5, 6. Some key points to consider:
- The study 2 used 20 IU of Humulin M3, but it does not specify this as a standard starting dose.
- The other studies do not provide information on the standard starting dose for Humilin M3. Key findings:
- The dose of 20 IU of Humulin M3 was used in a study comparing the pharmacokinetics and metabolic effects of human regular and NPH insulin mixtures 2.
- No other studies provided information on the standard starting dose for Humilin M3.